Stroke Trial, Recruiting NCT05085210 Sponsor: Beth Israel Deaconess Medical Center Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05085210
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have had your first-ever stroke (either a blockage-type or bleeding-type stroke) that damaged the main vision area of the brain, causing you to lose vision in part of your visual field
  • Brain scans (MRI or CT) show that some vision-related brain areas in the affected side of the brain are still intact
  • Brain scans confirm that the stroke mainly affected the vision area of the brain
  • Testing shows a clear loss of visual ability (simple or complex) in part of your visual field
  • If your stroke involved bleeding in the brain, it must have happened more than 6 months ago; if it involved a blockage, it can be either within 6 months or more than 6 months ago
  • You are willing and able to follow the study procedures as required

Who may not be able to join:

  • Your stroke did not damage the main vision area of the brain
  • Your vision loss was caused by a second or later stroke, not your first
  • You have completely lost vision across your entire visual field on both sides
  • You are unable to focus your eyes on a target or cannot perform the required visual training exercises
  • You have completely lost the ability to read
  • You have a neurological condition other than stroke, such as epilepsy, multiple sclerosis, or other brain lesions unrelated to your qualifying stroke
  • You currently have poorly controlled migraines or take regular medication to prevent migraines
  • You have a history of seizures, an epilepsy diagnosis, an abnormal brain wave test (EEG), or a close family member (parent, child, or sibling) with epilepsy — with a possible exception for a single, simple seizure (confirm with trial site)
  • You have a history of fainting episodes that may have been seizures
  • You have a past or current history of major depression, bipolar disorder, psychotic disorders, or another significant psychiatric condition
  • You have a condition called "one-sided attentional neglect," where your brain has difficulty paying attention to one side of the world (assessed through standard tests)
  • You have a medical reason that prevents you from receiving the brain stimulation used in this study (called tRNS) (confirm with trial site)
  • You have a serious, long-term uncontrolled medical condition that could become dangerous if a seizure were to occur (such as certain heart or breathing conditions)
  • You have any complex, unstable, or terminal illness
  • You have had a substance use problem within the past 6 months
  • You are currently taking certain medications — a study doctor will review your medications and decide if you are eligible based on your medical history and what you are taking
  • You are pregnant, breastfeeding, or — if you have not yet gone through menopause — you test positive on a pregnancy test
  • Your hairstyle or head covering (for example, thick braids, a hair weave, an afro, or a wig) prevents the study electrodes from making proper contact with your scalp
  • For one specific group in the study only: You have an implanted medical device such as a pacemaker, defibrillator, deep brain stimulator, or vagal nerve stimulator, which would prevent safe use of the virtual reality technology used in that group
  • The study investigators feel, for any reason, that the study may not be appropriate for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lorella Battelli, PhD, Beth Israel Deaconess Medical Center

Phone: 617-667-0326

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 January 2022
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Visual Motion Discrimination Change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov